Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Extra Strength Tylenol Cap Warning Prompts Label Reading

This article was originally published in The Tan Sheet

Executive Summary

Beginning in October, bottle caps of Extra Strength Tylenol will warn consumers the product contains acetaminophen and they should always read the label. The warning is the third element to highlight the ingredient on Extra Strength Tylenol but the redundancy may be necessary because consumers do not read labels.

You may also be interested in...



Research & Development In Brief: PPIs and B12 deficiency, multivitamins trim cataracts risk, vitamin E slows Alzheimer’s

Heartburn medicines raise B12 deficiency risk; multivitamins reduce cataracts risk; fat-soluble vitamin E slows Alzheimer’s; and modified acetaminophen overdose treatment reduces adverse events.

Research & Development In Brief: PPIs and B12 deficiency, multivitamins trim cataracts risk, vitamin E slows Alzheimer’s

Heartburn medicines raise B12 deficiency risk; multivitamins reduce cataracts risk; fat-soluble vitamin E slows Alzheimer’s; and modified acetaminophen overdose treatment reduces adverse events.

Cold Indication For Antihistamines Targeted In Regulatory Agenda

The latest regulatory agenda says FDA targets issuing proposed rules on OTC antimicrobial hand wash products in February and leave-on antiseptics in July, and in February to finalize an OTC monograph for oral bronchodilator in combination with expectorants or oral nasal decongestants.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS106587

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel